Clause 21 - Relationships and Contracts with Certain Organisations

Clause

Clause 21 Relationships and Contracts with Certain Organisations

Contracts between companies and institutions, organisations or associations of health professionals under which such institutions, organisations or associations provide any type of services on behalf of companies (or any other type of funding by the company
not otherwise covered by the Code) are only allowed if such services (or other funding):

comply with Clause 19.1 or are provided for the purpose of supporting research
do not constitute an inducement to prescribe, supply, administer, recommend, buy or sell any medicine.

Pharmaceutical companies must publicly disclose details of transfers of value made to such institutions, organisations or associations.

Supplementary information
Cases

Clause 21 Disclosure
The information required by Clause 21 must be publicly disclosed in relation to transfers of value made in 2015 and each calendar year thereafter, giving in each case the financial amount or value and the name of the recipient institution, organisation or association.

Fees and agreed expenses should be disclosed separately.

Disclosure must be carried out in accordance with Clause 24.

most recent cases See all Applicable Code year

Applicable Code year

Please check the date of the Code that applies to the Case that you are looking at. The date of the complaint may vary from the activity/material alleged to have been in breach.

AUTH/3755/3/23 - Health Professional v Novo Nordisk No breach: 2, 9.1, 18.1, 19.1, 19.2, 21 Applicable Code: 2019 Received: 23 March 2023 Completed: 25 January 2024 AUTH/3268/10/19 - Pharmacist v Merck Serono Breach: 2, 9.1, 9.10, 15.2, 15.4 No breach: 2, 3.2, 7.2, 9.1, 9.10, 15.2, 18.1, 20, 21 Applicable Code: 2019 Received: 24 October 2019 Completed: 14 August 2020

Interactive 2019 Code

Download 2019 Code

Changes to the 2016 Code and Constitution and Procedures